Status:
UNKNOWN
Ilioinguinal Nerve Block in Transcatheter Aortic Valve Implantation
Lead Sponsor:
Ain Shams University
Conditions:
Anesthesia
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
To assess the effect of iliohypogastric and ilioinguinal nerve block on the hemodynamic stability ,narcotic consumption and the rate of conversion to general anesthesia in patients undergoing transfem...
Eligibility Criteria
Inclusion
- • Patients undergoing TF-TAVI.
- Both sexes.
- Age 18 and above
Exclusion
- • Inability to tolerate supine position as in patients with musculoskeletal disease or back pain, OR in patients with congestive heart failure or with obstructive sleep apnea.
- Patients with severe pulmonary hypertension (PAP\>60 mmhg)
- Barrier to communications as language barrier or dementia.
- Patients' preference of general anesthesia.
- Surgical consideration as transapical, subclavian approach, extensive TEE requirements.
- Patients with history of allergy to any drugs used.
- Patients with psychiatric disease.
- Patients with neurocognitive or neurodegenerative disease.
- Secondary exclusion criteria include abortion of the procedure, perioperative emergency conversion to general anesthesia and the need to cardiopulmonary resuscitation so the primary endpoint couldn't be detected in these conditions.
Key Trial Info
Start Date :
November 11 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2022
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT05220813
Start Date
November 11 2021
End Date
May 1 2022
Last Update
February 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ismail Mohammed Ibrahim
Cairo, Egypt, 11765